vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $40.3M, roughly 1.2× Cambium Networks Corp). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -17.9%, a 13.2% gap on every dollar of revenue. On growth, Cambium Networks Corp posted the faster year-over-year revenue change (-23.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-10.8M). Over the past eight quarters, IRONWOOD PHARMACEUTICALS INC's revenue compounded faster (-20.2% CAGR vs -27.2%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

CMBM vs IRWD — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.2× larger
IRWD
$47.7M
$40.3M
CMBM
Growing faster (revenue YoY)
CMBM
CMBM
+24.1% gap
CMBM
-23.2%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
13.2% more per $
IRWD
-4.8%
-17.9%
CMBM
More free cash flow
IRWD
IRWD
$85.4M more FCF
IRWD
$74.6M
$-10.8M
CMBM
Faster 2-yr revenue CAGR
IRWD
IRWD
Annualised
IRWD
-20.2%
-27.2%
CMBM

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBM
CMBM
IRWD
IRWD
Revenue
$40.3M
$47.7M
Net Profit
$-7.2M
$-2.3M
Gross Margin
36.6%
Operating Margin
-28.4%
14.3%
Net Margin
-17.9%
-4.8%
Revenue YoY
-23.2%
-47.3%
Net Profit YoY
71.0%
-200.9%
EPS (diluted)
$-0.26
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
IRWD
IRWD
Q4 25
$47.7M
Q3 25
$122.1M
Q2 25
$85.2M
Q1 25
$41.1M
Q4 24
$40.3M
$90.5M
Q3 24
$44.7M
$91.6M
Q2 24
$45.2M
$94.4M
Q1 24
$47.1M
$74.9M
Net Profit
CMBM
CMBM
IRWD
IRWD
Q4 25
$-2.3M
Q3 25
$40.1M
Q2 25
$23.6M
Q1 25
$-37.4M
Q4 24
$-7.2M
$2.3M
Q3 24
$-34.5M
$3.6M
Q2 24
$-14.2M
$-860.0K
Q1 24
$-18.4M
$-4.2M
Gross Margin
CMBM
CMBM
IRWD
IRWD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
36.6%
Q3 24
43.6%
Q2 24
32.5%
Q1 24
29.8%
Operating Margin
CMBM
CMBM
IRWD
IRWD
Q4 25
14.3%
Q3 25
61.8%
Q2 25
53.2%
Q1 25
-70.7%
Q4 24
-28.4%
34.8%
Q3 24
-69.6%
28.0%
Q2 24
-27.2%
26.5%
Q1 24
-33.1%
14.7%
Net Margin
CMBM
CMBM
IRWD
IRWD
Q4 25
-4.8%
Q3 25
32.8%
Q2 25
27.7%
Q1 25
-90.9%
Q4 24
-17.9%
2.5%
Q3 24
-77.3%
4.0%
Q2 24
-31.5%
-0.9%
Q1 24
-39.2%
-5.6%
EPS (diluted)
CMBM
CMBM
IRWD
IRWD
Q4 25
$0.01
Q3 25
$0.23
Q2 25
$0.14
Q1 25
$-0.23
Q4 24
$-0.26
$0.03
Q3 24
$-1.22
$0.02
Q2 24
$-0.51
$-0.01
Q1 24
$-0.66
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$215.5M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-3.2M
$-261.8M
Total Assets
$173.7M
$396.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
IRWD
IRWD
Q4 25
$215.5M
Q3 25
$140.4M
Q2 25
$92.9M
Q1 25
$108.5M
Q4 24
$88.6M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
CMBM
CMBM
IRWD
IRWD
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$67.6M
$199.0M
Q3 24
$67.6M
$198.8M
Q2 24
$68.9M
$198.6M
Q1 24
$63.8M
$398.3M
Stockholders' Equity
CMBM
CMBM
IRWD
IRWD
Q4 25
$-261.8M
Q3 25
$-264.2M
Q2 25
$-308.2M
Q1 25
$-334.1M
Q4 24
$-3.2M
$-301.3M
Q3 24
$1.9M
$-311.3M
Q2 24
$34.1M
$-321.7M
Q1 24
$45.0M
$-330.5M
Total Assets
CMBM
CMBM
IRWD
IRWD
Q4 25
$396.9M
Q3 25
$396.1M
Q2 25
$342.9M
Q1 25
$327.2M
Q4 24
$173.7M
$350.9M
Q3 24
$194.3M
$389.5M
Q2 24
$221.1M
$395.6M
Q1 24
$219.8M
$438.8M
Debt / Equity
CMBM
CMBM
IRWD
IRWD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
IRWD
IRWD
Operating Cash FlowLast quarter
$-10.4M
$74.6M
Free Cash FlowOCF − Capex
$-10.8M
$74.6M
FCF MarginFCF / Revenue
-26.8%
156.3%
Capex IntensityCapex / Revenue
1.1%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
IRWD
IRWD
Q4 25
$74.6M
Q3 25
$47.6M
Q2 25
$-15.1M
Q1 25
$20.0M
Q4 24
$-10.4M
$15.2M
Q3 24
$8.9M
$9.9M
Q2 24
$2.4M
$33.5M
Q1 24
$-15.9M
$45.0M
Free Cash Flow
CMBM
CMBM
IRWD
IRWD
Q4 25
$74.6M
Q3 25
$47.6M
Q2 25
$-15.1M
Q1 25
$19.9M
Q4 24
$-10.8M
Q3 24
$6.8M
$9.9M
Q2 24
$87.0K
$33.4M
Q1 24
$-17.4M
$44.9M
FCF Margin
CMBM
CMBM
IRWD
IRWD
Q4 25
156.3%
Q3 25
39.0%
Q2 25
-17.7%
Q1 25
48.4%
Q4 24
-26.8%
Q3 24
15.2%
10.8%
Q2 24
0.2%
35.4%
Q1 24
-37.0%
60.0%
Capex Intensity
CMBM
CMBM
IRWD
IRWD
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
1.1%
0.0%
Q3 24
4.8%
0.0%
Q2 24
5.1%
0.1%
Q1 24
3.3%
0.1%
Cash Conversion
CMBM
CMBM
IRWD
IRWD
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

IRWD
IRWD

Segment breakdown not available.

Related Comparisons